3D Systems Corporation et al. v. Intrepid Automation, Inc.

Arashi Vision Inc. (d/b/a Insta360)vsGoPro, Inc.

The PTAB institution decision granted IPR for Arashi Vision (Insta360) against GoPro, finding a reasonable likelihood of prevailing on claims 1, 6, and 7. The Board found that the combination of Meulen and Chao renders these aspect ratio conversion claims obvious under 103.

ResMed Corp.vsCleveland Medical Devices, Inc.

ResMed Corp. successfully petitioned for institution of its IPR against Cleveland Medical Devices, Inc.'s patent covering CPAP systems. The Board declined discretionary denial, finding that the petitioner adequately demonstrated a reasonable likelihood of prevailing on both 102 and 103 grounds.

Pascal TechnologiesvsCambridge Enterprise Limited et al.

Pascal Technologies has initiated an IPR challenging the patentability of barocaloric cooling and heating agents held by Cambridge Enterprise Limited et al. The petition asserts that the challenged claims are obvious over various combinations of prior art, including Xie, Mañosa, and Patel.

Alamar Biosciences, Inc.vsOlink Proteomics AB et al.

The petitioner failed to prove the obviousness of claims 1-20 of U.S. Patent No. 7883848 in a Final Written Decision. The Board adopted a specific claim construction for 'selecting all cis-reactive cells exhibiting the detectable trace,' defining it as selecting associations of at least two interactor moieties joined by an associated oligonucleotide that exhibit the detectable trace.

CommScope Technologies LLC et al.vsBelden Canada ULC et al.

CommScope Technologies LLC successfully convinced the PTAB that U.S. Patent No. 11,656,422 B2 is likely unpatentable over prior art references Fukui and Sedor. The Board instituted the IPR on all 47 challenged claims based on grounds of anticipation and obviousness.